ACME UNITED CORP financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data ACME UNITED CORP files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	125	131	137	142	164	182	194	192	194	197
Cost of revenue	79	82.7	86.7	90.5	104	117	130	119	118	119
Gross profit	45.6	47.9	50.6	52	59.6	64.8	63.6	72.2	76.4	77.4
Research and development	0.75	0.75	0.73	0.6	0.25
Selling, general and administrative	37.1	40	43.2	43.6	48.2	52	57.3	59	62.2	62.7
Operating income	8.44	7.88	7.46	8.43	11.4	12.8	6.27	13.2	14.1	14.7
Interest expense	0.87	1.36	1.89	1.83	0.94	0.92	2.4	3.1	2.08	1.68
Interest income	0	0.03	0.03	0.04	0.02	0.01	0.03	0.12	0.14	0.12
Other non-operating income	-0.95	-1.39	-1.93	-1.89	-0.67	3.31	-0.25	12.5	0.1	-0.05
Pre-tax income	7.5	6.49	5.53	6.54	9.83	15.2	3.66	22.7	12.3	13.1
Income tax	1.65	2.44	0.93	1.03	1.73	1.52	0.63	4.94	2.27	2.93
Net income	5.85	4.05	4.6	5.51	8.1	13.7	3.03	17.8	10	10.2
EBITDA	10.8	10.8	10.7	11.9	15.3	16.8	10.9	18.2	20.2	21.1
EPS, basic	1.76	1.21	1.36	1.65	2.42	3.93	0.86	4.98	2.71	2.69
EPS, diluted	1.64	1.09	1.30	1.60	2.31	3.45	0.82	4.86	2.45	2.49
Shares, basic (weighted)	3.33	3.36	3.37	3.35	3.34	3.47	3.53	3.57	3.7	3.79
Shares, diluted (weighted)	3.58	3.72	3.54	3.45	3.51	3.96	3.72	3.66	4.1	4.09
Dividend per share	0.40	0.43	0.45	0.48					0.60	0.63

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	5.91	9.34	4.41	6.82	4.17	4.84	6.1	4.8	6.4	3.6
Receivables	20	26	25.1	25.5	27.2	34.2	32.6	26.2	28.2	29.1
Inventory	37.2	40.1	41.3	39.3	50.7	53.6	63.3	55.5	56.3	59.9
Other current assets	1.79	2.38	2.15	1.58	1.64	2.63	2.82	4.77	4.57	3.65
Total current assets	65	77.8	73	73.1	83.7	95.3	106	92	95.5	96.2
Property, plant and equipment	7.97	13.7	14.5	14	20.2	24	26.4	28	31.7	38.5
Lease right-of-use assets			2.9	2.99	2.42	3.13	2.63	2	4.83	6.88
Goodwill	3.95	4.7	4.7	4.7	4.8	4.8	8.19	8.19	9.91	9.91
Intangible assets	14	17.9	17	15.8	18.7	17.2	20.8	19	20.3	19.5
Other non-current assets	0.02	0.1	0.09	0.09
Total assets	92.1	115	109	111	130	144	164	149	162	171
Accounts payable	7.34	11.2	7.98	6.69	7.6	8.98	10.5	12.1	9	8.07
Accrued liabilities	5.48	5.37	5.12	8.58	11.5	9.91	10.1	12.4	11.9	12.9
Total current liabilities	12.8	16.8	13.4	16.6	20.2	20.3	22.1	26	22.9	22.9
Long-term debt	32.9	43.5	40.3	33.2	38.8	33	49.9	13.1	17.6	11.9
Lease liabilities				1.96	1.65	2.36	1.68	1.03	3.37	5.53
Other non-current liabilities	0.19	0.85	0.05	0.03	0.11	0.6	0.62	0.02	0.01	0.01
Total liabilities	45.9	64.8	57.1	55	67.2	67.4	85.3	51.3	55.2	53.4
Total debt	32.9	43.5	40.3	33.2	38.8	33	49.9	13.1	17.6	11.9
Paid-in capital	8.49	8.88	8.98	8.26	7.93	11.9	13.4	15.9	18	19.5
Retained earnings	41.9	44.5	47.5	51.6	58	69.9	71	86.7	94.5	102
Treasury stock	-13.9	-13.9	-14.2	-14.2	-14.5	-16	-16	-16	-16	-16
Other comprehensive income	-2.34	-1.63	-2.06	-1.99	-0.83	-1.38	-2.09	-1.71	-2.75	-1.57
Shareholders' equity	46.1	49.9	52.3	55.7	62.7	77.1	79	97.9	107	118
Total equity	46.1	49.9	52.3	55.7	62.7	77.1	79	97.9	107	118
Total liabilities and equity	92.1	115	109	111	130	144	164	149	162	171
Shares outstanding		4.84	4.84		3.34	3.52	3.54	3.65	3.75	3.81

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	5.85	4.05	4.6	5.51	8.1	13.7	3.03	17.8	10	10.2
Depreciation and amortization	2.39	2.9	3.23	3.43	3.84	4.05	4.58	5.01	6.07	6.35
Stock-based compensation	0.44	0.68	0.87	0.97	1.26	1.81	1.8	1.94	2.18	1.99
Deferred income tax	0.1	0.45	0.39	0.12	-0.1	0.49	-0.29	0.59	0.51	2.22
Change in receivables	0.5	-5.23	0.65	-0.78	-2.03	-7.23	1.84	6.33	-2.46	-0.59
Change in inventory	-1.48	-1.85	-1.58	2.09	-10	-3.21	-9.61	3.65	-0.33	-3.07
Change in payables	0.61	3.73	-3.07	-1.53	0.46	1.5	1.91	1.55	-2.98	-1.06
Cash from operations	8.86	4.81	4.48	14.7	5.72	5.14	2.89	28.9	12	18.2
Capital expenditures	-1.81	-3.15	-2.85	-1.68	-2.57	-6.37	-4.3	-4.67	-7.15	-10.7
Acquisitions							-9.62	-0.75	-0.75	-1.65
Cash from investing	-8.81	-14.4	-3.23	-1.68	-14	-6.37	-14.2	7.43	-12.9	-12.3
Stock issued	0.39	0.65			0.06	3.09	0.08	1.45	1.62	0.7
Share buybacks	-0.91		-0.37		-0.29	-1.47
Dividends paid	-1.33	-1.41	-1.48	-1.61	-1.6	-1.79	-1.9	-1.99	-2.22	-2.34
Cash from financing	3.47	12.9	-6.05	-10.6	5.29	2.04	14.3	-38.4	2	-8.88
Exchange rate effect	-0.03	0.09	-0.12	-0	0.29	-0.13
Net change in cash	3.48	3.43	-4.93	2.41	-2.65	0.68	2.76	-2.05	0.85	-2.8
Free cash flow	7.05	1.66	1.62	13	3.15	-1.23	-1.41	24.2	4.83	7.58
Interest paid	0.84	1.26	1.86	1.86	0.93	0.91	2.12	3.18	1.9	1.57
Income taxes paid	1.78	1.57	0.89	0.42	0.76	0.87	0.98	5.77	2.25	0.56

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $62.75 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	40.1%	Gross profit / revenue.
Operating margin	6.8%	Operating income / revenue.
EBITDA margin	10.3%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	5.9%	Pre-tax income / revenue.
Net margin	4.6%	Net income / revenue.
FCF margin	7.3%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	12.3%	Cash from operations / revenue.
Effective tax rate	21.2%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	8.1%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	4.9%	Net income / average total assets.
Return on invested capital (ROIC)	8.2%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	33.2%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	0.9%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	5.0%	Capital expenditures / revenue.
D&A / revenue	3.4%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	1.1%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	0.4%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	3.7%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	1.4%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	6.8%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	5.4%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	4.1%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	32.9%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	5.2%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	4.3%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	24.8%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	6.7%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	1.6%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	49.7%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	4.7%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	1.6%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	44.8%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	1.5%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	52.2%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	84.7%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	26.1%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	57.0%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 5y	19.2%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	5.0%	Dividend per share vs the same period a year earlier. Only from a positive base.
Book value growth, 1y	9.9%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	14.2%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	13.4%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	5.4%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	1.3%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	5.7%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-0.3%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	3.2%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	3.1%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	3.23x	Current assets / current liabilities.
Quick ratio	1.26x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.14x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.19x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	11.3%	Total debt / total assets.
Liabilities / assets	39.5%	Total liabilities / total assets.
Net debt	$17.6M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	0.81x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	7.86x	Operating income / interest expense.
Working capital	$77.5M	Current assets - current liabilities.
Goodwill and intangibles / assets	21.5%	(Goodwill + intangible assets) / total assets.
Tangible book value	$78.2M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.05x	Revenue / average total assets.
Fixed asset turnover	5.40x	Revenue / average property, plant and equipment.
Inventory turnover	1.98x	Cost of revenue / average inventory.
Days inventory	185 days	365 x average inventory / cost of revenue.
Receivables turnover	5.46x	Revenue / average receivables.
Days sales outstanding	67 days	365 x average receivables / revenue.
Days payables	41 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	211 days	Days inventory + days sales outstanding - days payables.
FCF conversion	157.7%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	40.7%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$2.37	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$51.10	Revenue / diluted weighted shares.
FCF per share	$3.74	Free cash flow / diluted weighted shares.
Operating cash flow per share	$6.31	Cash from operations / diluted weighted shares.
Book value per share	$31.64	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$20.40	Tangible book value / shares outstanding.
Cash per share	$1.31	(Cash + short-term investments) / shares outstanding.
Payout ratio	24.4%	Dividends paid / net income, when net income is positive.
Dividends / FCF	15.4%	Dividends paid / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$240.6M	Share price x shares outstanding.
Enterprise value	$258.2M	Market cap + total debt - cash - short-term investments.
P/E	24.5x	Market cap / net income. Only when net income is positive.
P/S	1.14x	Market cap / revenue.
P/B	1.98x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	3.08x	Market cap / tangible book value, when positive.
P/FCF	15.5x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	9.21x	Market cap / cash from operations, when positive.
EV/Sales	1.22x	Enterprise value / revenue.
EV/EBIT	17.8x	Enterprise value / operating income, when both are positive.
EV/EBITDA	11.9x	Enterprise value / EBITDA, when both are positive.
EV/FCF	16.7x	Enterprise value / free cash flow, when both are positive.
FCF yield	6.4%	Free cash flow / market cap.
Earnings yield	4.1%	Net income / market cap (the inverse of P/E).
Dividend yield	1.0%	Dividends paid over the period / market cap.
Shareholder yield	1.0%	(Dividends paid + share buybacks) / market cap.
PEG	0.55x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was ACME UNITED CORP's revenue in fiscal 2025?

ACME UNITED CORP reported revenue of $196.5M for fiscal 2025, 1.1% higher than the year before.

Was ACME UNITED CORP profitable in fiscal 2025?

Yes. Net income was $10.2M, a net margin of 5.2%.

How much free cash flow did ACME UNITED CORP generate in fiscal 2025?

Cash from operations of $18.2M minus capital expenditures of $10.7M left free cash flow of $7.6M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to ACME UNITED CORP